Approximately 33 percent of all patients currently eligible to receive lipid-lowering medication (statins) are not taking their medication, recent research published in the Journal of the American College of Cardiology suggests. The same study also showed that one every one in five patients would undergo unnecessary LDL retesting. Specific guidelines dictate whether patients fulfill the … [Read more...]
Cholesterol Drug Vytorin: Apparently Works, Data Shows
According to researchers at the American Heart Association who presented data from an randomized, double-blind study of 18,144 high-risk patients, it had been found that patients taking Vytorin, a combination of the cholesterol-lowering statin Zocor plus Zetia, a non-statin, experienced fewer heart attacks, strokes and repeat hospitalizations than those who were taking just statins. Lowering … [Read more...]